1. Home
  2. UPLD vs IMRN Comparison

UPLD vs IMRN Comparison

Compare UPLD & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Upland Software Inc.

UPLD

Upland Software Inc.

HOLD

Current Price

$3.96

Market Cap

11.1M

Sector

Technology

ML Signal

HOLD

Logo Immuron Limited

IMRN

Immuron Limited

HOLD

Current Price

$0.97

Market Cap

9.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UPLD
IMRN
Founded
2010
1994
Country
United States
Australia
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.1M
9.4M
IPO Year
2014
2016

Fundamental Metrics

Financial Performance
Metric
UPLD
IMRN
Price
$3.96
$0.97
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $12.50
N/A
AVG Volume (30 Days)
★ 67.2K
38.1K
Earning Date
11-04-2026
08-28-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 63.38
N/A
EPS
N/A
★ N/A
Revenue
★ $74,767,000.00
N/A
Revenue This Year
N/A
$16.39
Revenue Next Year
$0.58
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 6.95
N/A
52 Week Low
$0.50
$0.68
52 Week High
$6.65
$2.24

Technical Indicators

Market Signals
Indicator
UPLD
IMRN
Relative Strength Index (RSI) 56.05 38.44
Support Level $2.98 $0.73
Resistance Level $4.18 $1.00
Average True Range (ATR) 0.47 0.07
MACD 0.08 -0.01
Stochastic Oscillator 85.25 26.42

Price Performance

Historical Comparison
UPLD
IMRN

About UPLD Upland Software Inc.

Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels. Geographically, the company has operations in the U.S., United Kingdom and Canada, of which United States derives maximum revenue.

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.

Share on Social Networks: